Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Gilead To Acquire CGI Pharma | Contract Pharma

What are you searching for?

Sign in
Breaking News

Gilead To Acquire CGI Pharma

Gilead Sciences and CGI Pharmaceuticals, Inc. have entered into a definitive agreement under which Gilead will acquire CGI for as much as $120 million—the majority as an upfront payment and the rest based on clinical development progress.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Gilead Sciences and CGI Pharmaceuticals, Inc. have entered into a definitive agreement under which Gilead will acquire CGI for as much as $120 million—the majority as an upfront payment and the rest based on clinical development progress. CGI will continue operations in Branford as a wholly-owned subsidiary of Gilead. The deal is expected to close in 3Q10.

CGI has generated a library of small molecule kinase inhibitors. Its lead preclinical compound targets spleen tyrosine kinase (Syk), which has the potential to treat inflammatory diseases, including rheumatoid arthritis.

“The acquisition of CGI represents a unique opportunity to expand our research efforts in an interesting and promising area of drug discovery,” said Norbert W. Bischofberger, Ph.D., Gilead’s executive vice president, R&D and chief scientific officer. “CGI has established itself in the area of protein kinase biology and small molecule discovery, and the company’s scientific leadership and expertise represents a strong strategic fit with Gilead’s existing research organization. We look forward to advancing compounds in CGI’s portfolio toward clinical development.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics